Showcases SSi Mantra’s strengths in robotic telesurgery and opportunity in pediatricsFORT LAUDERDALE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the world’s first pediatric pyeloplasty telesurgery has been successfully performed utilizing the Company’s SSi Mantra ...

VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of a new Frequently Asked Questions (“FAQ”) page on its corporate website. The new FAQ resource, available at www.izocorp.c ...

Accessibility StatementSkip Navigation "We welcome Trinity Capital as a financing partner and appreciate their confidence in providing us this important financial flexibility as we continue our commercial expansion of our newly launch, next-generation Therapy Disc, and build upon our recent publication of what we believe is the largest long-term real-world data set for a permanent PNS device that demonstrated reliable long-term pain relief to a broad spectrum of patients," said Tom West, President and CEO ...

核心观点 - Elutia公司发布临床及临床前数据 支持其抗生素洗脱生物包膜在心脏植入电子设备(CIED)囊袋管理中的临床效用 该技术通过局部抗生素输送解决细菌定植问题 同时促进组织重塑并固定设备 [1][3][4] 临床研究数据 - HEAL研究(NCT04645173)显示 使用工程化细胞外基质(ECM)包膜的患者总体手术难度降低43% 其中发生器移动难度降低46% 导线移动难度降低41% [2] - 生物包膜不仅便于初始放置和设备稳定 还能长期保持囊袋的手术可及性 对可能需要再次干预的患者特别重要 [3] 临床前研究数据 - 临床前研究显示抗生素洗脱包膜能完全根除CIED相关并发症常见细菌接种物 包括MRSA等病原体 同时保持再生功能 [3] - 药代动力学评估证实局部抗生素浓度可持续维持长达两周 [3] 技术平台与应用拓展 - 再生性ECM与广谱协同抗生素(如利福平和米诺环素)结合形成强大平台 适用于组织重塑和感染控制交叉的外科环境 [4] - 公司基于该平台推进下一代产品管线 针对更高风险手术 如三分之一的患者会在重建后出现严重并发症的乳房重建领域 [4] 公司背景 - Elutia专注于开发和商业化药物洗脱生物基质产品 旨在改善医疗设备与患者之间的相容性 [5] - 公司使命是通过人性化医疗使患者能够无妥协地健康成长 [5]

公司人事任命 - 医疗设备公司Insulet任命行业资深人士Flavia Pease担任新任首席财务官 [1] 财务表现 - 公司预计第三季度总营收将超过先前发布的指引 [1]

US FDA 510(k) Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company Preparing for US Commercial Launch following ClearanceCoronary Intravascular Imaging Market Expected to Grow to over $1 bil USD by 2028 TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to ...

Focal One® HIFU Receives Prestigious Innovation Award AUSTIN, Texas, September 16, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced today that the company has been honored with the 2025 Industry Award for Innovations in Endourological Instrumentation by the Endourological Society in recognition of its groundbreaking work with the Focal One High-Intensity Focused Ultrasound (HIFU) platform. Focal One is the first Focal Therapy technology to receive this dist ...

Since my last publication on LeMaitre Vascular, Inc. (NASDAQ: LMAT ) from June last year, the stock is +12% to the upside, with growth in both the capital and income accounts. I noted in the last report that "Equity strategist (US Equities)Technical focus on fundamental value drivers of business economics to uncover high probability long-term compounders. Seeking to buy at appropriate prices relative to intrinsic worth. Partners are represented over the cross-section of financial markets, from speculators, ...

截至10:30，A股主要指数翻绿。科创50指数逆市涨超2%。持仓股龙芯中科、海光信息、澜起科技、传 音控股、华海清科涨幅居前。 （文章来源：每日经济新闻） 中国银河称，AI产业将进入高速发展通道。2025年~2035年，中国AI产业将进入高速发展通道，成为驱 动经济长期增长的关键力量。回顾中国信息技术发展历程，呈现出从"技术跟跑"到"系统并跑"再到"逐 步引领"的清晰轨迹。与技术相伴随的，是中国经济增长底层逻辑由"土地财政"转向"数据要素"，并朝 着"智能原生"目标前进。展望2035年，结合政策红利释放与技术渗透节奏，AI核心产业规模在乐观、中 性、悲观情景下将分别达到36.63万亿元、24.92万亿元、16.72万亿元。 科创50ETF（588000）追踪科创50指数，指数持仓电子行业68.77%，医药生物行业9.85%，合计 78.62%，行业分布集中。同时涉及半导体、医疗器械、软件开发、光伏设备等多个细分领域，硬科技 含量高。从当前位置来看，科创50指数仍在基点附近，参照创业板历史走势，未来成长空间值得期待。 看好中国硬科技长期发展前景的投资者建议持续关注。 ...

aTyr Pharma, Inc. (NASDAQ:ATYR) experienced a significant price drop of approximately 82.67%, with a surge in trade volume, indicating high investor activity.Kindly MD, Inc. (NASDAQ:NAKA) saw its stock price fall by 53.24% following the approval for options trading on the Nasdaq Options Market.Syra Health Corp. Class A Common Stock (NASDAQ:SYRA) reported a 40% decrease in stock price, despite showing a 197% growth in its Population Health segment and an improvement in earnings per share.In the recent market ...